Related Experiment Video

Updated: Mar 21, 2026

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

13.2K

MicroRNA's impact on neurotransmitter and neuropeptide systems: small but mighty mediators of anxiety

Stefanie Martinetz1

  • 1Department of Behavioural and Molecular Neurobiology, University of Regensburg, Universitaetsstrasse 31, Regensburg, Germany. Stefanie.Martinetz@ur.de.

Pflugers Archiv : European Journal of Physiology
|May 4, 2016
PubMed

Insights

MicroRNAs (miRNAs) show promise for treating anxiety and mood disorders by regulating neurotransmitter and neuropeptide systems. This review explores their impact on brain circuitry and potential as novel therapeutic targets.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Psychiatry

Background:

  • Psychiatric disorders, including anxiety and depression, are a significant global health burden with unclear patient outcomes.
  • Current treatments for mental disorders have limitations and unpleasant side effects.
  • Brain circuitry, neurotransmitter systems, and neuropeptides are key to mood regulation and anxiety formation.

Purpose of the Study:

  • To review the impact of microRNAs (miRNAs) on neurotransmitter and neuropeptide systems in the central nervous system relevant to anxiety disorders.
  • To discuss the therapeutic potential of miRNAs for anxiety and mood disorders.

Main Methods:

  • Literature review focusing on molecular mechanisms and neurobiology.
  • Analysis of the role of non-coding RNAs, specifically miRNAs, in regulating neuronal function.
  • Examination of miRNA interactions with neurotransmitter and neuropeptide systems.

Main Results:

  • MicroRNAs (miRNAs) play a crucial role in post-transcriptional regulation of genes involved in neuronal signaling.
  • Alterations in miRNA expression are linked to the molecular basis of anxiety and mood disorders.
  • miRNAs modulate key neurotransmitter and neuropeptide systems implicated in mental health.

Conclusions:

  • MicroRNAs represent a promising frontier for developing novel therapeutic strategies for psychiatric disorders.
  • Targeting miRNA pathways offers a potential avenue for more effective and targeted treatments for anxiety and mood disorders.
  • Further research into miRNA function is essential for translating these findings into clinical applications.
Keywords:
Anxiety disorderMicroRNANeuropeptideNeurotransmitterSerotonin

More Related Videos

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

8.2K
Stereotactic Injection of MicroRNA-expressing Lentiviruses to the Mouse Hippocampus CA1 Region and Assessment of the Behavioral Outcome09:06

Stereotactic Injection of MicroRNA-expressing Lentiviruses to the Mouse Hippocampus CA1 Region and Assessment of the Behavioral Outcome

Published on: June 10, 2013

23.8K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

12.0K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.9K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Neurotransmitters01:31

Neurotransmitters

Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
3.4K